Drug store chain reports revenue and adjusted earnings that topped estimates as it prepares to be taken private ...

Time is running out for some Walgreens shoppers to file for their part of a proposed class action settlement that accuses the pharmacy chain of overcharging for generic drugs.

Walgreens Boots Alliance entered into a $10 billion definitive agreement with private equity firm Sycamore Partners to take ...

Walgreens Boots Alliance Inc. shares ended ... continues to work on a turnaround in a challenging landscape. The drugstore industry is facing competition from the likes of Amazon.com Inc. (AMZN ...

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Those Walgreens shoppers will have until June ... This resolution allows us to focus on our turnaround strategy that will benefit our patients, customers, team members and shareholders.

Walgreens Boots Alliance Inc. shares ended Tuesday’s session down 1.1% after the drugstore chain reported better-than-expected second-quarter revenue and adjusted earnings, boosted by an ...